Submitted by Anonymous (not verified) on 21 October 2025 - 13:20
Human medicines European public assessment report (EPAR): Rayvow, lasmiditan, Date of authorisation: 17/08/2022, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Rayvow, lasmiditan, Date of authorisation: 17/08/2022, Revision: 5, Status: Authorised